| Literature DB >> 23552878 |
Min Zhao1, Jian Yin, Wei Jiang, Minshan Ma, Xinxiang Lei, Zheng Xiang, Jianyong Dong, Kexin Huang, Pengcheng Yan.
Abstract
Chemical examination of a South China Sea soft coral Lobophytum sp. led to the isolation of three new α-methylene-γ-lactone-containing cembranoids, (1R*,3R*, 4R*,14R*,7E,11E)-3,4-epoxycembra-7,11,15(17)-trien-16,14-olide (1), (1R*,7S*,14S*,3E, 11E)-7-hydroperoxycembra-3,8(19),11,15(17)-tetraen-16,14-olide (2), and (1R*,7S*,14S*, 3E,11E)-18-acetoxy-7-hydroperoxycembra-3,8(19),11,15(17)-tetraen-16,14-olide (3), along with eleven known analogues 4-14. The structures of the new compounds were elucidated through extensive spectroscopic analysis, including 1D and 2D NMR data. Compounds 1-3 exhibited moderate cytotoxic activity against the selected tumor cell lines. Moreover, 2 and 3 were found to be moderate inhibitors against the bacteria S. aureus and S. pneumoniae.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23552878 PMCID: PMC3705396 DOI: 10.3390/md11041162
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Structures of compounds 1–14.
13C NMR data for compounds 1–3 (CDCl3, 150 MHz).
| No. | 1, δC, type | 2, δC, type | 3, δC, type |
|---|---|---|---|
| 1 | 42.6, CH | 45.1, CH | 45.0, CH |
| 2 | 26.0, CH2 | 31.7, CH2 | 32.1, CH2 |
| 3 | 62.3, CH | 121.1, CH | 127.4, CH |
| 4 | 60.8, C | 137.2, C | 135.9, C |
| 5 | 38.7, CH2 | 34.7, CH2 | 30.6, CH2 |
| 6 | 23.9, CH2 | 28.6, CH2 | 28.6, CH2 |
| 7 | 122.3, CH | 84.5, CH | 84.2, CH |
| 8 | 135.1, C | 149.2, C | 149.0, C |
| 9 | 38.1, CH2 | 33.5, CH2 | 33.4, CH2 |
| 10 | 25.0, CH2 | 28.4, CH2 | 28.5, CH2 |
| 11 | 130.1, CH | 128.0, CH | 128.4, CH |
| 12 | 129.6, C | 131.3, C | 131.0, C |
| 13 | 42.7, CH2 | 44.6, CH2 | 44.7, CH2 |
| 14 | 77.1, CH | 81.7, CH | 81.3, CH |
| 15 | 138.3, C | 139.2, C | 138.9, C |
| 16 | 169.9, C | 170.2, C | 169.9, C |
| 17 | 120.8, CH2 | 121.9, CH2 | 122.5, CH2 |
| 18 | 16.5, CH3 | 16.3, CH3 | 61.9, CH2 |
| 19 | 16.2, CH3 | 111.6, CH2 | 111.9, CH2 |
| 20 | 15.8, CH3 | 17.5, CH3 | 17.6, CH3 |
| –OAc | – | – | 20.9, CH3 |
| –OAc | – | – | 171.0, C |
1H NMR data for compounds 1–3 (CDCl3, 600 MHz).
| No. | 1, δH ( | 2, δH ( | 3, δH ( |
|---|---|---|---|
| 1 | 3.36, ddd (10.8, 7.2, 3.6) | 2.79, m | 2.81, m |
| 2 | a: 2.16, m | a: 2.33, m | |
| b: 1.42, ddd | b: 2.25, m | 2.41, m | |
| (14.4, 10.2, 3.6) | |||
| 3 | 2.58, dd (10.2, 1.2) | 5.16, t (7.2) | 5.43, t (7.2) |
| 5 | a: 2.11, m | a: 2.24, m | a: 2.34, m |
| b: 1.14, m | b: 2.10, m | b: 2.22, m | |
| 6 | a: 2.16, m | a: 1.76, m | a: 1.77, m |
| b: 2.13, m | b: 1.67, m | b: 1.73, m | |
| 7 | 4.95, dd (7.2, 1.8) | 4.35, dd (7.8, 4.2) | 4.35, dd (8.4, 4.8) |
| 9 | a: 2.21, m | a: 2.34, m | a: 2.36, m |
| b: 2.06, m | b: 2.00, m | b: 2.01, m | |
| 10 | a: 2.39, m | a: 2.33, m | a: 2.26, m |
| b: 2.10, m | b: 2.25, m | b: 2.24, m | |
| 11 | 5.11, br d (9.0) | 5.23, t (7.2) | 5.24, t (7.2) |
| 13 | a: 2.44, br d (14.4) | a: 2.47, dd (14.4, 4.8) | a: 2.49, dd (13.8, 4.2) |
| b: 2.38, dd (14.4, 10.8) | b: 2.07, dd (14.4, 7.2) | b: 2.06, dd (13.8, 6.6) | |
| 14 | 4.97, m | 4.30, m | 4.33, m |
| 17 | a: 6.26, d (2.4) | a: 6.28, d (2.4) | a: 6.30, d (2.4) |
| b: 5.52, d (2.4) | b: 5.63, d (2.4) | b: 5.67, d (2.4) | |
| 18 | 1.27, s | 1.66, s | 4.62, s |
| 19 | 1.62, s | a: 5.13, br s | a: 5.13, br s |
| b: 5.08, br s | b: 5.09, br s | ||
| 20 | 1.74, s | 1.67, s | 1.68, s |
| –OAc | – | – | 2.09, s |
| –OOH | – | 7.78, br s | 7.92, br s |
Figure 2COSY and HMBC correlations of compounds 1–3.
Figure 3Key NOE correlations and computer-generated models using MM2 force field calculations for compounds 1 and 2.
Cytotoxicity data of compounds 1–3.
| Compounds | IC50 (μg/mL) | ||||
|---|---|---|---|---|---|
| SGC7901 | A549 | MCF7 | HCT116 | B16 | |
|
| 5.3 | 6.1 | 3.8 | 5.2 | 8.6 |
|
| 2.7 | 3.2 | 1.2 | 4.5 | 2.1 |
|
| 2.3 | 1.8 | 2.9 | 3.4 | 5.6 |